Comparative results in detection of HCV antibodies by using a rapid HCV test, ELISA and immunoblot.

Machine translation Machine translation
类别 Primary study
期刊The Southeast Asian journal of tropical medicine and public health
Year 1994
連結 Pubmed
病毒性丙型肝炎是输血后肝炎的一个主要问题。最好的措施，以防止输血感染C型肝炎的献血者筛选。检测丙型肝炎病毒抗体的方法有很多种。ELISA是的敏感筛选方法之一。然而，它需要的设备，技术精湛，是非常耗时。Genelabs诊断HCV-SPOT是一种简单，快速检测抗-HCV的检测。本文中丙型肝炎病毒抗体的检测报告比较的结果，使用GLD的HCV-SPOT，ELISA和GLD /后海湾干线HCV BLOT。 HCV现场检测和HCV酶联免疫吸附百92献血者慢性肝炎，肝硬化，肝癌及杂项慢性肝病患者的标本进行了测试。阳性标本的免疫印迹法确认。140个样本中只有一个阴性的HCV-SPOT阳性ELISA。 HCV-SPOT检测的敏感性和特异性分别为97.6％和92.6％。阳性预测值分别为78.8％，阴性预测值99.3％，准确性为93.6％。HCV-SPOT快速检测试剂盒可用于移植移植手术或紧急输血的血源筛查的管理。此外，它可以无需任何昂贵的设备中使用小，当地医院。
This translation has been produced by an automated software. If you wish to submit your own translation, please send it to translations@epistemonikos.org
Epistemonikos ID: e134c37e6cfd0c40157e61c068dacad74fddb6d7
First added on: Oct 24, 2012
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: English

If you prefer to see the machine translation we assume you accept our terms of use